Rate of moderate/severe exacerbations over a 52 week treatment period. [clinicaltrials_resource:e12599db2072ef1ee80dff82bde1c4a5]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Rate of moderate/severe exacerbations over a 52 week treatment period. [clinicaltrials_resource:e12599db2072ef1ee80dff82bde1c4a5]
Bio2RDF identifier
e12599db2072ef1ee80dff82bde1c4a5
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e12599db2072ef1ee80dff82bde1c4a5
measure [clinicaltrials_vocabulary:measure]
Rate of moderate/severe exacerbations over a 52 week treatment period.
identifier
clinicaltrials_resource:e12599db2072ef1ee80dff82bde1c4a5
title
Rate of moderate/severe exacerbations over a 52 week treatment period.
@en
type
label
Rate of moderate/severe exacer ...... 599db2072ef1ee80dff82bde1c4a5]
@en